Navigation Links
Genomenon and Limbus Partner to Advance Genomic Variant Interpretation
Date:4/11/2021

Genomenon® announced a partnership with Limbus Medical Technologies, which includes integration of the Mastermind® Genomic Search Engine into the cloud-based varvis® platform. In the initial integration available now, users of varvis can preview the number of published articles related to their search and easily link out to view the evidence in Mastermind. A deeper integration using Mastermind’s advanced API is underway, which will allow users to view the relevant evidence right inside the varvis platform.

The collaboration stemmed from a shared desire to provide clinicians with the best decision support possible. The integration of virtually all relevant literature into the analysis process of genomic data will make the flood of new data manageable and allow both clinicians and patients to take full advantage of the information generated by next generation sequencing. Leveraging genetic data and clinical evidence is the key to improving the diagnosis of rare diseases and making informed decisions with confidence.

The varvis genomics platform is a complete solution for clinical diagnostics, supporting NGS raw data processing, genomics data management, and variant interpretation. Designed as a clinical decision support system (CDS), varvis also comprises a comprehensive variant database that allows you to review, filter, and classify genetic variants.

Mastermind is the world’s only comprehensive genomic search engine, connecting patient’s genomic data with evidence from the scientific literature - a key requirement in analyzing a patient’s DNA in precision medicine for cancer and genetic diseases. By leveraging the full-text content of millions of genomic research articles, Mastermind has created a comprehensive database of over 7 million published variants across all genes and gene elements, updated on a weekly basis.

“The deep integration of Mastermind into varvis is a very logical step in the evolution of our products,” explains Dr. Ben Liesfeld, Managing Director of Limbus. “It brings the most rapidly growing collection of scientific genomic literature into the patient-centered varvis cockpit so that the clinician can view all relevant information for this specific patient at a glance.”

“We’re excited to partner with Limbus to put the most comprehensive and up-to-date genomic research in the hands of geneticists and researchers performing genomic analysis,” said Mike Klein, CEO of Genomenon. “Our relationship extends Mastermind’s global reach, and connecting Mastermind with varvis provides significant value in cutting turnaround time and increasing diagnostic yield for genetic labs.”

About Genomenon

Genomenon is an AI-driven genomics company that organizes the world’s genomic knowledge to connect patient DNA to scientific research in the diagnosis and development of treatments for patients with rare genetic diseases and cancer.

Genomenon was named Global Company of the Year in Clinical Genomics Interpretation by Frost & Sullivan.

For more information, visit Genomenon.com

About Limbus Medical Technologies

Limbus Medical Technologies GmbH is a medical device manufacturer and software development company and created the clinical decision support system varvis®. Besides NGS data analysis and variant interpretation, our services comprise first class support, training, automated quality control and validation compliant with relevant international guidelines. varvis® is a registered CE-IVD device and specifically designed to aid in the diagnosis of patients.

For more information, visit: varvis.com

Read the full story at https://www.prweb.com/releases/genomenon_and_limbus_partner_to_advance_genomic_variant_interpretation/prweb17795233.htm.


'/>"/>
Source: PRWeb
Copyright©2021 Vocus, Inc.
All rights reserved


Related biology news :

1. Genomenon Accelerates Rare and Genetic Disease Research with Mastermind v2.0
2. TGen and Riddell announce partnership for biomarker study of concussive injuries
3. The DOE Joint Genome Institute expands capabilities via new partnerships
4. Emotient and iMotions Partner to Offer Unique Integrated Facial Expression Recognition, Bio Sensor and Eye Tracking Solution for Usability, Gaming, Market and Academic/ Scientific Research
5. NOAA, partners predict possible record-setting deadzone for Gulf of Mexico
6. Advance Research Associates Partners With MedNet Solutions
7. Transatlantic partnership to tackle neurodegenerative disease
8. Newly discovered bacterial partnership changes ocean chemistry
9. 4 projects awarded Discovery Transformation Grant funding by Minnesota Partnership
10. AKESOgen and Identitas partner to provide a comprehensive Next Generation Forensic profiling solution
11. Nice genes! What makes you genetically compatible with your partner?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2021)... ... March 25, 2021 , ... Phlexglobal announced ... Planet Group, has selected Phlexglobal and its innovative regulatory SaaS software, PhlexSubmission, as ... a comprehensive review of five regulatory software companies, with the review team including ...
(Date:3/27/2021)... ... 25, 2021 , ... The 2021 Virtual Conference on Clinical Trial Supply-Europe ... More and more, clinical trial supply conferences are featuring speakers and forums that ... Asymmetrex’s founder and CEO, James L. Sherley, M.D., Ph.D., presented a talk ...
(Date:3/23/2021)... ... March 23, 2021 , ... G-CON Manufacturing (G-CON), the ... by Matica Biotechnology (Matica Bio), a contract development and manufacturing organization (CDMO) specializing ... the cleanroom build out for its new GMP production facility in College Station, ...
Breaking Biology News(10 mins):
(Date:3/27/2021)... ... March 24, 2021 , ... ... Life Sciences and Healthcare firms of all sizes, adds depth to its team ... specialist. Pardillo, who earned his doctorate in computational chemistry from Florida International University ...
(Date:3/27/2021)... ... March 24, 2021 , ... ABI Wellness, ... and reporting approach designed under CEO Mark Watson, today announced a webinar dedicated ... featuring guest speakers Dr. Cameron Clark, Neuropsychologist and Founder of Sharp Thinking, and ...
(Date:3/27/2021)... ... ... The Xtalks editorial team is pleased to announce the launch of the ... joined by editorial team members Ayesha Rashid, Sydney Perelmutter and Mira Nabulsi to discuss ... including insights from industry experts. , The Xtalks Life Science podcast will feature ...
(Date:3/23/2021)... Conn. (PRWEB) , ... March 23, 2021 , ... ... develops solutions for characterizing microbiome populations down to the strain level, recently unveiled ... applications. , Not all microbes are created equal: some are easy to ...
Breaking Biology Technology: